Physician
Hematology
Doctor John C. Michalak, MD is an expert in the field of Hematology. He went to medical school at University of California Irvine School of Medicine. University of California Irvine School of Medicine has a rank of 45 in research and a 62 in primary care John C. Michalak, MD is also published. He has 31 publications published. The lastest publication: "Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.'
Publications
- Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic mel...
- Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
- Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes'' B2 or C colon Cancer: a North Cen...
- Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients.
- Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast Cancer...
- Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastom...
- Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
- Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group.
- Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.
- Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic Cancer: a North Central Ca...
- Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
- Phase III evaluation of four doses of megestrol acetate as therapy for patients with Cancer anorexia and/or cachexia.
- Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blin...
- Lack of effect of coumarin in women with lymphedema after treatment for breast Cancer.
- Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy.
- Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell Carcinoma: a phase II study.
- A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast Cancer.
- A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with Chronic lym...
- Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with Cancer anorexia and/or cachexia.
- Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic Leukemia.
- Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
- Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
- Phase II trial of edatrexate in small cell lung Cancer.
- Alleviation of Cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
- Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung Cancer: a phase II study of the North Central Cancer Treatment Group.
- Transdermal fentanyl in the management of Cancer pain in ambulatory patients: an open-label pilot study.
- Alleviation of cytotoxic therapy-induced normal tissue damage.
- Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis.
- Megestrol acetate for the prevention of hot flashes.
- [The efficacy of subterranean therapy in the salt chamber of Kinga Spa in Wieliczka for patients suffering from allergic rhinitis].
Schools
University of California At Irvine California College of Medicine amp Surgery
Fitzsimons Army Med Center
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of California Irvine School of Medicine
Drug Facts
| NPI NUMBER |
|
1922057934 |
| NPPES Provider LastName |
|
MICHALAK |
| NPPES Provider FirstName |
|
JOHN |
| NPPES Provider ZIPCode |
|
930109274 |
| NPPES Provider State |
|
CA |
| Specialty Description |
|
Physician Assistant |
| Total Claim Count |
|
197.0 |
| Distinct Opioid Count |
|
1.0 |
| Opioid Claim Count |
|
46.0 |
| Percent Opioid Claims |
|
23.35 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1922057934 |
| Last Name Of The Provider |
MICHALAK |
| First Name Of The Provider |
JOHN |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.